SME Times is powered by   
Search News
Just in:   • Sensex, Nifty open lower as US-Iran war uncertainty keeps crude prices elevated  • PM Modi pitches for 100 GW nuclear capacity, 50 companies in Fortune 500 list  • BRICS discuss linking CBDCs and fast payment systems: RBI Governor Malhotra  • Piyush Goyal calls for fair trade and recycling as India eyes $30 trillion economy by 2047  • “Quality, innovation, and trust define every solution at Viraj Pipes.”: Yogendra Kumar Singh 
Last updated: 13 Mar, 2023  

Tablet.9.Thmb.jpg Centre mulling taking action against e-pharmacies over data misuse

Tablet.9.jpg
   Top Stories
» Sensex, Nifty open lower as US-Iran war uncertainty keeps crude prices elevated
» PM Modi pitches for 100 GW nuclear capacity, 50 companies in Fortune 500 list
» Piyush Goyal calls for fair trade and recycling as India eyes $30 trillion economy by 2047
» India’s merchandise exports touched record high at $129.6 bn in Q1 of FY27: Minister
» MSME Amendment Bill improves regulatory flexibility, scalability: Industry
IANS | 14 Mar, 2023
The Centre is planning to regulate the e-pharmacy industry over misuse of data, sources said.

According to a source, the Health Ministry is working on a policy to regulate the e-pharmacy industry market in the country, and a Group of Ministers (GoM) are in favour of the closure of e-pharmacies. "They did not propose the idea in the present shape. The government can take action against them," the source said.

"Health Ministry has taken note of malpractices reported in the sector which lead to concerns over data privacy, sales of medicines without prescription, and predatory pricing," the source added.

The action follows after the Drugs Controller General of India (DCGI) last month issued a show-cause notice on online pharmacies asking them why action should not be taken against them for selling and distributing drugs without licence.

The notice was issued to online pharmacies including Tata 1mg, Amazon, and Flipkart, for selling and distributing drugs in contravention of provisions of the Drugs and Cosmetics Act, 1940.

"This office has received various representations from time to time raising concerns regarding sale of drugs through online, internet or other electronic platforms including various mobile applications, in contravention to the provisions of the Drugs and Cosmetics Act, 1940 & Rules there under. Such sale includes drugs specified in Schedule H, HI and X which are only allowed to be sold by retail under a valid prescription of a registered medical practitioner and supplied under the supervision of a registered pharmacist," the DCGI had said in the notice.
 
Print the Page
Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
₹95.3
₹93.6
UK Pound
₹127.7
₹123.7
Euro
₹110.65
₹106.9
Japanese Yen ₹59.75 ₹57.9
As on 24 Jun, 2026
  Daily Poll
What’s your biggest challenge with the 45-day payment rule?
 Corporates canceling our orders
 Clients demanding longer credit anyway
 Strained business relationships
 Filing complaints kills future work
 No issues, cash flow has improved
  Commented Stories
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter